Biosynex Cash Flow Reinvestment Rate

Latest as of December 2024: 2.19x

Biosynex cash flow reinvestment rate. Biosynex (ALBIO) has a Cash Flow Reinvestment Rate of 2.19x as of December 2024, reinvesting €2.77 Million (capex €2.77 Million ) from operating cash flow of €1.26 Million. Explore how well can Biosynex service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

2.19x
(Capex + Investments) / Operating CF

Total Reinvested

€2.77 Million
Capex + Investments

Operating Cash Flow

€1.26 Million
EUR

Capital Expenditures

€2.77 Million
EUR

Cash Flow Reinvestment Rate of Biosynex (2009–2022)

Cash flow reinvestment rate of Biosynex from 2009 to 2022. Historical reinvestment intensity for Biosynex across 9 annual periods. Explore reinvestment intensity of Biosynex to see what proportion of operating cash flow is directed to capital expenditures.

Biosynex Cash Flow Reinvestment Rate by Year (2009–2022)

Biosynex cash flow reinvestment rate by year from 2009 to 2022. Year-by-year capital reinvestment analysis for Biosynex. For the full cash flow conversion analysis, see Biosynex (ALBIO) cash flow conversion.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2022 13.98x €69.16 Million €4.95 Million €30.08 Million ▲ +3101.6%
2021 0.44x €47.98 Million €109.83 Million €19.02 Million ▼ -18.9%
2020 0.54x €17.04 Million €31.64 Million €9.12 Million ▼ -93.5%
2019 8.26x €9.12 Million €1.10 Million €9.12 Million ▼ -57.7%
2018 19.52x €9.12 Million €467.12K €9.12 Million ▲ +3.8%
2017 18.81x €9.12 Million €484.82K €9.12 Million —
2016 0.00x €0.00 €489.91K €0.00 —
2015 0.00x €0.00 €461.66K €0.00 ▼ -100.0%
2009 0.65x €46.92K €72.40K €46.92K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow